HIP
WST icon

HUB Investment Partners’s West Pharmaceutical WST Stock Holding History

HUB Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689K Buy
1,919
+767
+67% +$234K 0.01% 577
2026
Q1 		$289K Buy
1,152
+334
+41% +$83.1K 0.01% 835
2025
Q4 		$225K Buy
818
+45
+6% +$12.3K 0.01% 800
2025
Q3 		$203K Buy
+773
New +$188K 0.01% 695
2024
Q4 		– Sell
-2,225
Closed -$668K – 655
2024
Q3 		$668K Hold
2,225
– – 0.03% 255
2024
Q2 		$733K Hold
2,225
– – 0.03% 227
2024
Q1 		$880K Hold
2,225
– – 0.05% 190
2023
Q4 		$783K Buy
+2,225
New +$787K 0.05% 181

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

HUB Investment Partners's WST Position: Q2 2026 in Review

HUB Investment Partners increased its West Pharmaceutical (WST) stake by 67% in Q2 2026, buying an estimated $234K and bringing the position to 1,919 shares worth $689K. The position accounts for 0.01% of the portfolio, ranked #577.

HUB Investment Partners first reported a position in WST in Q4 2023 and has held it in 8 quarters since. The position peaked at $880K in Q1 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • HUB Investment Partners held 1,919 shares of West Pharmaceutical worth $689K as of Q2 2026.
  • HUB Investment Partners bought 767 West Pharmaceutical shares in Q2 2026, an estimated $234K.
  • West Pharmaceutical made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #577 holding.
  • HUB Investment Partners first reported a position in West Pharmaceutical in Q4 2023 and has held it in 8 quarters since.
  • HUB Investment Partners's West Pharmaceutical position peaked at $880K in Q1 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.